JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
ESPR Financials - Esperion Therapeutics Income & Cash Flow | Ledgeburg
ESPR - Esperion Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary ESPR Stock
Financials
Financials ESPR Stock
Loading...
Loading...
Income Statement
Income Statement ESPR Stock
Balance Sheet
Balance Sheet ESPR Stock
Cash Flow Statement
Cash Flow Statement ESPR Stock
Loading...
Loading...
Home
Stocks
Esperion Therapeutics, Inc. (ESPR)
Financials
Financials of ESPR
Loading...
Loading...
Loading...
Loading...
Revenue
$403.135M
Operating Income
$60.273M
Net Income
$-22.682M
Share Count (Basic)
207.86508M
Operating Cash Flow
$-13.093M
Free Cash Flow
$-13.093M
Cash And Short-Term Equivalents
$167.852M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
400M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50M
100M
150M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-250M
-200M
-150M
-100M
-50M
Annual
Quarterly
Margins
Gross
Operating
Net
-300%
-200%
-100%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-40M
-20M
0
20M
40M
60M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-50%
0%
50%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26